SUMMARY: Physicians are not testing cancer patients for biomarkers even as new biomarker targeted therapies are being introduced by pharma companies. Pharma companies, like AZ, are going to have to educate the public on biomarker testing.
SUMMARY: Physicians are not testing cancer patients for biomarkers even as new biomarker targeted therapies are being introduced by pharma companies. Pharma companies, like AZ, are going to have to educate the public on biomarker testing.